` Comparison: ARWR vs CANF - Alpha Spread

ARWR
vs
C
CANF

Over the past 12 months, ARWR has significantly outperformed CANF, delivering a return of +221% compared to the CANF's 89% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ARWR
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ARWR Intrinsic Value
18.1 USD
Overvaluation 72%
Intrinsic Value
Price
C
CANF Intrinsic Value
5 120.66 ILS
Undervaluation 86%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
63.87 USD
C
Can Fite Biopharma Ltd
TASE:CANF
698.1 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ARWR, CANF

ARWR
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Arrowhead Pharmaceuticals Inc
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ARWR, CANF

ARWR
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ARWR
0%
CANF
0%

Operating Margin

ARWR
27.6%
CANF
-1 487.2%

Net Margin

ARWR
18.5%
CANF
-1 456.2%

FCF Margin

ARWR
29.5%
CANF
-953.8%

ROE

ARWR
65.1%
CANF
-382.9%

ROA

ARWR
15.5%
CANF
-187%

ROIC

ARWR
49.9%
CANF
-6 189.1%

ROCE

ARWR
27.6%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ARWR, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ARWR, CANF

Loading
ARWR
CANF
Difference
www.alphaspread.com

Performance By Year
ARWR, CANF

Loading
ARWR
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ARWR to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account